Jazz Pharmaceuticals
JAZZ
#2291
Rank
NZ$10.47 B
Marketcap
$172.45
Share price
3.03%
Change (1 day)
-6.17%
Change (1 year)

Earnings for Jazz Pharmaceuticals (JAZZ)

Earnings in 2024 (TTM): NZ$0.77 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's current earnings are NZ$4.06 Billion. , an increase over its 2023 earnings that were of NZ$0.49 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jazz Pharmaceuticals from 2005 to 2024

Annual earnings

Year Earnings Change
2024 NZ$0.78 B57.87%
2023 NZ$0.49 B-179.92%
2022 -NZ$0.63 Billion230.37%
2021 -NZ$0.19 Billion-141.02%
2020 NZ$0.45 B-39.45%
2019 NZ$0.75 B-14.2%
2018 NZ$0.88 B20.03%
2017 NZ$0.73 B-17.15%
2016 NZ$0.88 B22.14%
2015 NZ$0.72 B187.64%
2014 NZ$0.25 B-50.79%
2013 NZ$0.51 B73.63%
2012 NZ$0.29 B41.69%
2011 NZ$0.20 B116.61%
2010 NZ$96.39 M262.77%
2009 NZ$26.57 M-111.33%
2008 -NZ$0.24 Billion1.31%
2007 -NZ$0.24 Billion77.8%
2006 -NZ$0.14 Billion36.59%
2005 -NZ$95.33 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$3.99 Billion-608.54%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
NZ$3.49 B 345.78%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$22.75 B 2,799.96%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-NZ$0.48 Billion-159.96%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel